Paul Lin is the Chief Strategy Officer for OMD China. Paul started his career during Dot Com, when the first wave of the Internet was the Wild West and nobody had a business model. He fell in love with technology & the start-up culture and carried that passion to world class Ad Agencies like DDB, BBDO, Wunderman and Saatchi.

Paul has worked across multiple categories and markets for some of the best brands in the world. He is passionate about the creative process, and specializes in crafting integrated solutions that solve client's business problems. When Paul is not working with clients, he's working with the Marketing and Tech community in China to help drive advocacy and policy. In his spare time, he is the 'Chair" of the Marketing & Media Committee at the American Chamber of Commerce. In addition, he acts as a Mentor to a couple of Accelerator programs in Shanghai and works closely with start-ups and entrepreneur's to help guide them through the China business environment.

John D Van Fleet currently serves as Director, Corporate Globalization, and adjunct faculty, Antai College of Economics & Management, Shanghai Jiao Tong University, a campus where he's been based since 2003. For nearly a decade through 2017, Van Fleet also served as Assistant Dean, USC Marshall School of Business, and Executive Director, USC-SJTU Global Executive MBA in Shanghai.

Previously, Van Fleet led two marketing consultancies, one in Taipei and one in Shanghai, and served as Asia Pacific marketing and communications manager for GE's healthcare division, based in Tokyo, from 1996 to 2000. A regular reviewer for the Asian Review of Books, Van Fleet speaks and writes often about business, education and society in China and East Asia. His book Tales of Old Tokyo was published in 2015, while his second book, Squabbling Siblings, China and Japan from Antiquity to 2022, will be published in early 2019. John served as Chair of the Education Committee at AmCham Shanghai.

Shirley Zhao is currently General Manager and President of Bristol-Myers Squibb mainland China and Hong Kong. Shirley is among the first batch of locally grown senior business executives with truly global perspectives and management expertise, since China adopts the "Open and Reform" policy. Shirley joined BMS China back in 1993, when she led the team to introduce the then paradigm-shifting chemo treatment Taxol® to China market, which set her up for her future success in the oncology area in China. Over the last two decades, Shirley held a number of senior management positions in multinational companies, including Vice President of Oncology Business of Eli Lilly China, Commercial Director of Biomedicine Business for Baxter Japan, China and North Asia, General Manager of Genzyme China, and most recently, Country President of Allergan China.

Shirley served as Board of Directors of the American Chamber of Commerce in Shanghai (AmCham) in 2015. She was a representative of the AmCham Annual Washington D.C. DoorKnock Meeting in 2015 & 2016.